Baxiva
1 known investors
Find your way into Baxiva
Sign up to see every warm intro you have to Baxiva
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Baxiva team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Baxiva is a biotechnology startup developing glycoconjugate vaccines to prevent bacterial infections with high clinical burden and antimicrobial resistance. Its lead program targets urinary tract and invasive infections caused by Escherichia coli.
Investors · 1
Frequently asked questions
- What does Baxiva do?
- Baxiva is a biotechnology startup developing glycoconjugate vaccines to prevent bacterial infections with high clinical burden and antimicrobial resistance. Its lead program targets urinary tract and invasive infections caused by Escherichia coli.
- Who are Baxiva's investors?
- Baxiva's investors include Kickfund.
